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RESEARCH ARTICLE
Mitochondrial DNA Depletion in
Respiratory Chain–Deficient Parkinson
Disease Neurons
Anne Gr€unewald, PhD,1,2,3 Karolina A. Rygiel, PhD,1
Philippa D. Hepplewhite, MSc,1 Christopher M. Morris, PhD,4
Martin Picard, PhD, DHom,5 and Doug M. Turnbull, MD, PhD, FRCP1
Objective: To determine the extent of respiratory chain abnormalities and investigate the contribution of mtDNA to
the loss of respiratory chain complexes (CI–IV) in the substantia nigra (SN) of idiopathic Parkinson disease (IPD)
patients at the single-neuron level.
Methods: Multiple-label immunofluorescence was applied to postmortem sections of 10 IPD patients and 10 controls
to quantify the abundance of CI–IV subunits (NDUFB8 or NDUFA13, SDHA, UQCRC2, and COXI) and mitochondrial
transcription factors (TFAM and TFB2M) relative to mitochondrial mass (porin and GRP75) in dopaminergic neurons.
To assess the involvement of mtDNA in respiratory chain deficiency in IPD, SN neurons, isolated with laser-capture
microdissection, were assayed for mtDNA deletions, copy number, and presence of transcription/replication-associ-
ated 7S DNA employing a triplex real-time polymerase chain reaction (PCR) assay.
Results: Whereas mitochondrial mass was unchanged in single SN neurons from IPD patients, we observed a signifi-
cant reduction in the abundances of CI and II subunits. At the single-cell level, CI and II deficiencies were correlated
in patients. The CI deficiency concomitantly occurred with low abundances of the mtDNA transcription factors TFAM
and TFB2M, which also initiate transcription-primed mtDNA replication. Consistent with this, real-time PCR analysis
revealed fewer transcription/replication-associated mtDNA molecules and an overall reduction in mtDNA copy num-
ber in patients. This effect was more pronounced in single IPD neurons with severe CI deficiency.
Interpretation: Respiratory chain dysfunction in IPD neurons not only involves CI, but also extends to CII. These defi-
ciencies are possibly a consequence of the interplay between nDNA and mtDNA-encoded factors mechanistically
connected via TFAM.
ANN NEUROL 2016;79:366–378
Parkinson disease (PD) is a progressive movement dis-order characterized by tremor, rigidity, bradykinesia,
and postural instability that affects about 1% of those
aged> 65 years.1 The pathological hallmarks of PD are
selective loss of dopaminergic neurons and the presence
of Lewy bodies in the substantia nigra (SN).2
Mitochondrial dysfunction has emerged as a poten-
tial mechanism in PD. Soon after the detrimental effects
of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on motor
function were described and the inhibitory action of the
toxin against respiratory chain complex I (CI) was unrav-
eled,3 isolated CI deficiency was discovered in homoge-
nates from postmortem SN samples of PD patients.4 The
importance of this finding was emphasized when familial
PD cases were found to harbor mutations in proteins
involved in the removal of damaged mitochondria or the
scavenging of reactive oxygen species that are predomi-
nantly generated by the electron transport chain.5
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A study aiming to elucidate the molecular under-
pinnings of mitochondrial dysfunction in idiopathic PD
(IPD) patients at the single-cell level identified an accu-
mulation of respiratory chain complex IV (CIV)-deficient
SN neurons with large somatic mtDNA deletions.6 Inter-
estingly, the primary risk factor for PD development is
ageing, which is itself correlated with the presence of
CIV-deficient neurons at similar levels to patients with
IPD,6,7 suggesting that age-related damage accumulation
could contribute to neuronal demise in IPD.6,7
However, in the investigated IPD patients,6 CIV-
negative SN neurons constituted <3% of the total num-
ber of analyzed cells, a fraction well below the detection
limit in traditional homogenate analysis. In comparison,
the postmortem results from Schapira and colleagues4
imply an impairment of CI that is of sufficient magnitude
to be detected in SN homogenates. Due to the lack of a
robust histochemical method for the assessment of CI
activity in single neurons, it has remained elusive whether
mtDNA damage also underlies CI deficiency in IPD.
In this study, we aimed to determine the relative
incidence of respiratory chain abnormalities and the
molecular mechanisms underlying the loss of respiratory
chain complexes in individual dopaminergic neurons
from IPD patients. To establish the extent and relation-
ship of these deficiencies in single neurons rather than
SN homogenate, we employed quantitative quadruple
immunofluorescence as an indicator of respiratory chain
complex function at single-cell resolution.8 In combina-
tion with laser-capture microdissection (LCM) and real-
time polymerase chain reaction (PCR) analysis, this
approach revealed altered levels of factors responsible for
crosstalk between mitochondrial and nuclear compart-
ments as a cause of respiratory chain dysfunction in IPD.
Subjects and Methods
Human Brain Tissue
Brain tissue was obtained from the Newcastle Brain Tissue
Resource with ethical approval. Sections from paraffin-
embedded midbrain tissue of 10 IPD patients and 10 age-
matched controls (patients, mean6 standard error [SE]:
75.06 1.8 years; controls, mean6 SE: 76.16 4.1 years;
p5 0.80) with comparable postmortem interval (PMI; patients
[5 of them female], mean6 SE: 38.76 4.5 hours; controls [4
of them female], mean6 SE: 45.86 7.5 hours; p5 0.43) were
used in this study. IPD patients had a mean (6SE) age at dis-
ease onset of 65.96 1.2 years. Clinical and neuropathology
information is summarized in the Table. Sections were cut at
5 lm using a microtome (Microm International, Walldorf, Ger-
many) and mounted onto SuperFrostTM slides (Thermo Fisher
Scientific, Waltham, MA).
For mtDNA analysis in single cells, sections were cut
from frozen midbrain blocks on a cryostat (Bright Instruments,
Huntingdon, UK) at a thickness of 15lm. Sections were stored
at 280 8C, thawed, and allowed to air dry for 60 minutes at
room temperature (RT) before immunohistochemistry was
performed.
Immunofluorescence Detection of Target
Proteins in Formalin-Fixed Brain Slices
We have previously established quantitative quadruple-
immunofluorescence as a sensitive tool to assess respiratory
chain deficiencies at the single-neuron level in postmortem tis-
sue.8 In this study, this approach was applied to paraffin-
embedded midbrain sections using the following primary anti-
bodies (all Abcam, Cambridge, MA) to target different subunits
of respiratory chain complexes: CI, anti-NDUFB8 (NADH
dehydrogenase 1 beta subcomplex 8; ab110242) and anti-
NDUFA13 (NADH dehydrogenase 1 alpha subcomplex 13;
ab110240); CII, anti-SDHA (succinate dehydrogenase complex
subunit A; ab14715); CIII, anti-UQCRC2 (ubiquinol–cyto-
chrome c reductase core protein II; ab14745); and CIV, anti-
COXI (cytochrome c oxidase subunit I; ab14705). The selected
subunits are situated in functional domains correlating with the
overall abundance of the respiratory chain complexes.8–13 Addi-
tional mitochondrial antibodies included: anti-porin (Abcam,
ab14734), anti-GRP75 (heat shock 70kDa protein 9 [mortalin];
Abcam, ab53098), anti-TFAM (mitochondrial transcription fac-
tor A; Abcam, ab47517), and anti-TFB2M (mitochondrial
transcription factor B2; Sigma, St Louis, MO; HPA030265).
To identify dopaminergic neurons, a rabbit anti–TH antibody
(tyrosine hydroxylase; Sigma, T8700) was employed. Imaging
using Axio Imager M1 (Zeiss, Oberkochen, Germany), and
subsequent densitometric analysis of the acquired images was
conducted as detailed in Gr€unewald et al.8 To rule out that the
samples’ PMIs negatively impacted on the abundance of the
target proteins, we performed Spearman correlation analyses
with PMI delay and mitochondrial protein levels as variables.
This did not show a significant decline in protein levels as a
result of higher PMI intervals.
Immunofluorescence Detection of Target
Proteins in Frozen Brain Slices
In formalin-fixed sections, the yield and quality of mtDNA are
reduced to such an extent that molecular analyses, especially in
single cells, are impeded. To simultaneously determine the cel-
lular abundance of CI and the levels of mtDNA in single SN
neurons from IPD patients and controls, we optimized our
immunofluorescence protocol for use with frozen brain tissue.
The previously employed anti-porin and anti-GRP75 antibodies
showed nonspecific labeling in frozen midbrain sections and
therefore could not be used. Furthermore, anti-NDUFA13,
which provided a stronger signal in frozen tissue, was preferred
over anti-NDUFB8 in this experiment. In view of the results
from fixed tissue, we considered the mitochondrial mass
unchanged in IPD patients and carried out immunofluores-
cence labeling to detect NDUFA13 only. Sections were dried
for 60 minutes at RT, fixed in 4% (wt/vol) paraformaldehyde
for 10 minutes, then washed in H2O for 10 minutes and in
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Tris-buffered saline containing 3% Tween-20 (TBST) for 5
minutes. Sections were blocked in TBST and 1% normal goat
serum (NGS) for 1 hour at RT. Anti-NDUFA13 was diluted at
1:100 in blocking solution, and slides were incubated overnight
at 4 8C. Following the primary antibody incubation, sections
were washed 3 times in TBST for 5 minutes. An anti-mouse
IgG2b secondary antibody (A-21141; Life Technologies, Carls-
bad, CA) was diluted at 1:100 in 1% NGS TBST and applied
for 60 minutes at RT. Following 3 washes in TBST, sections
were incubated in Sudan black solution for 10 minutes to
quench autofluorescence. Finally, sections were washed in H2O
for 10 minutes to remove Sudan black and air dried.
Mapping of SN Neurons for Isolation from Brain
Slices by LCM
Following densitometric analysis of all neuromelanin-positive
SN neurons, neurons within a midbrain section were classified
according to their absolute NDUFA13 levels. Ten neurons with
high and 10 neurons with significantly (p< 0.0004) lower
NDUFA13 levels but comparable neuromelanin content (as
determined by densitometric analysis of the monochrome
bright-field image) were identified. These neurons were then
mapped in a high-resolution bright-field image of the entire
nigral region for each subject. The neurons of interest were
located in the brain section, laser-microdissected using a PALM
MicroBeam (Zeiss), captured individually in 10ll of lysis
buffer, and incubated as previously described.14 This procedure
was performed for 5 randomly selected IPD patients (compare
in the Table: IPD2, IPD6, IPD7, IPD9, and IPD10).
Mitochondrial DNA Deletion, Copy Number,
and Replication Analysis
A triplex real-time PCR assay for simultaneous detection of 3
targets within the mitochondrial genome (ND1 [NADH dehy-
drogenase 1], ND4, and D-loop) was performed.15 The quanti-
fication of ND1 and ND4 was conducted as previously
published.16 For mtDNA copy number quantification, the
ND1 concentration per unit area was calculated. To detect
mtDNA major arc deletions, the ND1:ND4 was determined.
The third target amplified in the triplex assay was located
within an area of the noncoding region that is preserved in
99% of deleted mtDNA species reported to date.15,17,18 During
TABLE. Clinical and Neuropathology Features of IPD Patients
Patient Sex Age at
Onset,
yr
Age at
Death,
yr
Clinical
IPD
LB
Pathology
Neuron
Loss
Additional Features
IPD1 M 65 67 Affected Positive 111 Mild cognitive impairment,
depression, anxiety
IPD2 M 66 77 Affected Positive 111 Dementia, visual hallucinations
IPD3 M 71 79 Affected Positive 111 Dementia, strokelike episodes,
episodes of delirium
IPD4 M 66 81 Affected Positive 111 Cognitive impairment, visual
hallucinations, confusion
IPD5 M 69 76 Affected Positive 111 Mild cognitive impairment,
visual hallucinations, confusion
IPD6 F 60 65 Affected Positive 11 Mild cognitive impairment,
depression, visual hallucinations,
anxiety
IPD7 F 62 77 Affected Positive 11 Depression, anxiety, agitation
IPD8 F 62 71 Affected Positive 111 Mild cognitive impairment,
psychosis, complex hallucinations
(visual, auditory,
olfactory, and tactile)
IPD9 F 66 81 Affected Positive 111 Dementia, impaired consciousness,
visual and auditory hallucinations
IPD10 F 72 76 Affected positive 11 Confusion, dyskinesia
Average6 SE 65.96 1.2 75.06 1.8
115moderate;1115 severe; F5 female; IPD5 idiopathic Parkinson disease; LB5 Lewy body; M5male; SE5 standard
error.
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transcription and replication, a linear DNA molecule, that is,
7S DNA, is incorporated in this particular region of the mito-
chondrial genome, resulting in a triple-stranded structure
denominated as “D-loop.”17,19 The D-loop:ND1 ratio is there-
fore representative of the mtDNA replication status in a given
cell, with a higher ratio representing more actively transcribed or
replicating mtDNA molecules.20 Two microliters of cell lysates
from individual SN neurons were used per real-time PCR reac-
tion, and all measurements were performed in triplicates. Stand-
ard curves were generated by serial dilution of a DNA plasmid
containing a single copy of each mtDNA target.15
To explore a link between the mitochondrial genome and
CI abundance at the single-cell level, the mtDNA deletion lev-
els, copy numbers, and replication efficiency were quantified in
individually laser-captured NDUFA13-positive and NDUFA13-
negative patient SN neurons.
Moreover, to obtain a general picture of mtDNA integ-
rity and copy number in patients and controls, pooled SN neu-
rons from 10 controls and 9 IPD patients (frozen midbrain
sections were unavailable for IPD5) were analyzed using the
same real-time PCR assay. Thirty randomly selected SN neu-
rons containing comparable neuromelanin levels were isolated
from each tissue section as described and captured in a single
tube in 20ll lysis buffer. The experiment was conducted on 3
separate occasions per subject.
Statistical Analysis
Densitometric analyses of individual SN neurons resulted in
non-normally distributed data in some cases. To account for
this distribution, median values per person were calculated. In
each run, the same control served as internal standard and its
median abundance or median ratio of abundances was set to
100%. The differences between average patient and control
group values in respect to protein abundances or mtDNA dele-
tion levels, copy number, and mtDNA transcription/replication
efficiency were assessed using unpaired 2-sample t tests. To
compare the ND1:area and D-loop:ND1 ratios in individually
laser-captured CI-deficient or CI-normal neurons isolated from
the same individual, paired 2-sample t tests were employed.
Finally, the Spearman rank correlation coefficient (r2), associ-
ated p-value, and frequency distributions were calculated to
evaluate the relationship between different parameters in the
study. For statistical analysis, Prism 6.0 software (GraphPad,
San Diego, CA) was used.
Results
CI and CII Deficiency in Single Nigral Neurons
from IPD Patients
IPD patient characteristics are presented in the Table. Cell
size analysis, immunofluorescence detection, and densito-
metric quantification of mitochondrial protein levels were
performed in individual SN neurons from 10 IPD patients
and 10 age-matched controls (Fig 1). For each investigated
parameter, means per person were derived. Calculation of
the mean cell area showed that patient neurons were sig-
nificantly smaller than control neurons. By contrast, the
assessment of the mitochondrial mass marker porin at the
single-neuron level indicated comparable mitochondrial
densities in patients and controls.
Next, we quantified the average neuronal protein
abundance of the CI subunit NDUFB8 relative to mito-
chondrial mass (NDUFB8:porin ratio) in the patients
and controls. In agreement with previous immunohisto-
chemical studies,9,21 we detected a significant reduction
(60.5% of the control level) of NDUFB8 levels in the
patient neurons (see Fig 1). Subsequently, we determined
the abundance of the CII subunit SDHA. CII is the only
complex of the electron transport chain entirely com-
posed of nuclear-encoded subunits. Quantification of
SDHA:porin ratios in the SN neurons of all individuals
showed a decrease in the amount of CII (65.5% of the
control level) in patients. By contrast, assessment of the
UQCRC2:porin ratio in individual neurons indicated no
difference in the average CIII levels between patients and
controls. Similarly, comparable CIV levels were found in
neurons from patients and controls as quantified by the
COXI:porin ratio.
Relationship of CI, CII, and CIV in Single IPD
Patient Neurons
To correlate CI, CII, and CIV abundancies in single IPD
patient and control neurons, we immunolabeled the CI
subunit NDUFA13 along with SDHA (CII) and COXI
(CIV). To simultaneously assess mitochondrial mass in
neurons in this experimental setting, the anti-porin anti-
body was replaced by an antibody against the outer mito-
chondrial membrane protein GRP75.22 Thus, antibody
isotype mismatches between anti-NDUFB8 and anti-
SDHA as well as between anti-porin and anti-
NDUFA13 were circumvented. Results obtained using
the anti-GRP75 antibody confirmed that mitochondrial
content is similar in patients and controls (Fig 2). Quan-
tification of the mean ratios per person of NDU-
FA13:GRP75, SDHA:GRP75, and COXI:GRP75 also
confirmed reduced neuronal CI and CII abundances as
well as normal CIV levels in patients.
Regarding the relationship of CI and CII, Spear-
man correlation analysis revealed that the variance of
NDUFA13:GRP75 accounts for 25% of the variance of
SDHA:GRP75 in single control neurons (r25 0.25,
p< 0.0001; see Fig 2). In patient neurons, this interde-
pendency was increased to 49% (r25 0.49, p< 0.0001).
To explore the link between loss of CI and CII in IPD
in more detail, we defined objective thresholds for
mitochondria-normalized NDUFA13 and SDHA. SN
neurons that fell below the 25th percentile of the control
range for NDUFA13:GRP75 or SDHA:GRP75 were
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considered to express low levels of the respective respira-
tory chain subunit and are denominated as “deficient”
hereafter. Interestingly, 49.1% of all IPD patient SN neu-
rons lacked both CI and CII. Patient cells lacking only
CI (10.6%) or only CII (10.6%) were equally frequent,
resulting in overlapping frequency distributions of NDU-
FA13:SDHA for patient and control neurons.
Because CIV deficiency has previously been impli-
cated in IPD, we also wanted to explore the relation-
ships between CIV and CI, as well as between CIV and
CII at the single-neuron level. In respect to CI and
CIV, Spearman correlation analysis showed that 61% of
the variance of NDUFA13:GRP75 was explained by the
variance of COXI:GRP75 in single control neurons
(r25 0.61, p< 0.0001; see Fig 2). In patient neurons,
this correlation was slightly reduced to 51% (r25 0.51,
p< 0.0001). Employing the above-described strategy to
establish deficiency cutoffs for NDUFA13:GRP75 and
COXI:GRP75, 34.3% of patient neurons showed
NDUFA13 deficiency without COXI involvement.
About a quarter of the cells (25.3%) lacked both
NDUFA13 and COXI. By contrast, neurons with iso-
lated COXI deficiency were extremely rare (1.3%). In
agreement with these observations, an overall shift of
the NDUFB8:COXI ratio toward COXI was detected
in IPD patient SN neurons. Further supporting a core-
gulation of CI and CIV, the average neuronal abun-
dance of mitochondrial-normalized NDUFB8 and
FIGURE 1: Abundances of subunits of respiratory chain complexes CI–IV and mitochondrial mass in dopaminergic substantia
nigra (SN) neurons from idiopathic Parkinson disease (IPD) patients and controls (Cnt). (A–C) Epifluorescence microscopy after
quadruple-label immunofluorescence indicated reduced levels of the CI subunit NDUFB8 and the CII subunit SDHA in IPD
patient neurons, whereas the CIII subunit UQCRC2, the CIV subunit COXI, and the mitochondrial mass marker porin were
unchanged. The investigated neurons were tyrosine hydroxylase (TH) -positive and contained neuromelanin deposits indicative
of their dopaminergic character. Deficiencies are marked by an asterisk. (D) Despite their significantly smaller size, (E) densito-
metric analysis of area-normalized porin levels indicated unchanged mitochondrial mass in patient neurons. In agreement with
the results from the visual inspection, the average (F) NDUFB8:porin and (G) SDHA:porin ratios in IPD patient neurons were
significantly reduced. By contrast, (H) UQCRC2:porin and (I) COXI:porin ratios were comparable in control and patient SN neu-
rons. Lines indicate mean group ratios. **p<0.01. COXI5 cytochrome c oxidase subunit I; NDUFB85NADH dehydrogenase 1
beta subcomplex 8; SDHA5 succinate dehydrogenase complex subunit A; UQCRC25ubiquinol–cytochrome c reductase core
protein II.
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COXI showed a similar rate of decline with age in con-
trols (Fig 3).
Assessment of the relationship between CII and
CIV (ie, SDHA:GRP75 and COXI:GRP75) indicated
little correlation in control neurons (r25 0.24,
p< 0.0001; see Fig 2) but a markedly increased depend-
ency in patient neurons (r25 0.49, p< 0.0001), suggest-
ing enhanced coregulation of CII and CIV in IPD
patient neurons. The majority of deficient patient neu-
rons lacked either SDHA and COXI (24.3%) or SDHA
FIGURE :2.
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alone (35.4%). By contrast, isolated COXI deficiency
was rare (2.4%), resulting in a shift of the SDHA:COXI
ratio toward COXI.
CI Deficiency Coincides with Loss of TFAM and
TFB2M
Next, we explored whether the loss of the partially
mtDNA-encoded CI is associated with impaired mtDNA
transcription in IPD. The expression of mtDNA-encoded
subunits of the respiratory chain is controlled by
TFAM.23,24 TFAM protein abundance was quantified
along with NDUFB8 and porin in the same cells. The
average neuronal TFAM:porin ratio per person indicated
significantly (p5 0.02) reduced protein levels of the tran-
scription factor in IPD patients (64.0% of the control
level) compared to controls (Fig 4A, B). In addition, the
NDUFB8:porin and TFAM:porin ratios in single neurons
were strongly correlated for both patients (r25 0.74,
p< 0.0001) and controls (r25 0.72, p< 0.0001). The rel-
ative frequency of neurons with different NDUFB8:TFAM
ratios was comparable in patients and controls, as indicated
by overlapping frequency distributions (see Fig 4C).
To further ascertain a possible link between
mtDNA transcription and CI deficiency in IPD, the pro-
tein levels of another mitochondrial transcription factor,
TFB2M,25 were assessed. As for TFAM, the average neu-
ronal TFB2M:porin ratio per person was significantly
(p5 0.04) reduced in IPD patients (50.3% of the control
level) compared to controls (see Fig 4D, E). Further-
more, mitochondria-normalized NDUFB8 and TFB2M
were moderately and equally correlated in individual IPD
patient (r25 0.57, p< 0.0001) and control (r25 0.54,
p< 0.0001) SN neurons, resulting in similar frequency
distributions of NDUFB8:TFB2M (see Fig 4F).
mtDNA Depletion in IPD Patient Neurons
In addition to their role as transcription factors, TFAM
and TFB2M are involved in mitochondrial genome pack-
aging26,27 and replication.23,28 Consequently, we sought to
test whether loss of either factor is associated with mtDNA
copy number and stability in SN neurons of IPD patients.
Real-time PCR quantification of the mitochondrial
copy number (ND1:area) in pooled SN neurons from con-
trols and patients showed significantly (p5 0.026) fewer
mtDNA copies in IPD patient cells (73.1% of the control
level; Fig 5A). In addition, using our triplex real-time PCR
assay, we measured the levels of 7S DNA, which associates
with the mitochondrial genome in the D-loop region in a
transcription/replication-dependent manner. The D-
loop:ND1 ratio indicated significantly (p5 0.004) fewer 7S
DNA molecules per mitochondrial genome in patient neu-
rons (90.9% of the control level; see Fig 5B), linking mtDNA
depletion to impaired mtDNA replication in IPD. Of note,
the prevalence of mtDNA deletions in pooled neurons did
not differ between patients and controls (data not shown).
MtDNA Depletion Correlates with CI Deficiency
To explore whether the observed mtDNA depletion in
IPD patient SN neurons correlates with CI deficiency at
the single-cell level, we isolated individual NDUFA13-
positive and NDUFA13-negative neurons from 5 IPD
patients. Real-time PCR analysis revealed significantly
(p5 0.041) lower mtDNA copy numbers (ND1:area) in
NDUFA13-deficient neurons (Fig 6). On average,
NDUFA13-negative patient neurons harbored 29.4%
fewer mtDNA copies per cell area than NDUFA13-
positive patient neurons. Consistent with this result,
quantification of mtDNA-associated 7S DNA indicated
significantly (p5 0.014) fewer mtDNA transcription/
FIGURE 2: Dependencies between respiratory chain complexes CI, CII, and CIV in single control (Cnt) and idiopathic Parkinson
disease (IPD) patient substantia nigra (SN) neurons. (A–D) Densitometric analysis of the mitochondrial mass marker GRP75, the
CI subunit NDUFA13, the CII subunit SDHA, and the CIV subunit COXI in patient and control SN neurons. Calculation of mean
neuronal protein abundances per person confirmed reduced levels of mitochondria-normalized CI and CII in IPD patients. (E)
Spearman correlation analysis of NDUFA13:GRP75 and SDHA:GRP75 ratios indicated a weak link between the protein levels of
both complexes in individual control neurons. The lower 25th percentile of the control ranges for NDUFA13:GRP75 and
SDHA:GRP75 were used to define thresholds of deficiency (broken lines and shaded areas). (F) In patient neurons, the associa-
tion between NDUFA13:GRP75 and SDHA:GRP75 was increased. Applying the deficiency thresholds, 49.1% of cells lacked
both NDUFA13 and SDHA. Equal proportions of cells (10.6%) showed either isolated NDUFA13 or SDHA deficiency. (G) This
caused overlapping frequency distributions of NDUFA13:SDHA in patient and control cells. (H, I) Spearman correlation analysis
of NDUFA13:GRP75 and COXI:GRP75 revealed coregulation of CI and CIV in individual control and patient neurons. About a
quarter of patient cells (25.3%) were deficient for NDUFA13 and COXI. In 34.3% of all patient neurons, isolated NDUFA13
deficiency occurred, whereas isolated COXI deficiency was only present in 1.3% of cells. (J) An overall decrease in NDUFA13
resulted in a shift of the NDUFA13:COXI ratio in IPD patient neurons relative to the control population. (K) Spearman correla-
tion analysis of the SDHA:GRP75 and COXI:GRP75 ratios indicated a weak dependency between CII and CIV in control cells.
(L) In patient neurons, this coregulation increased as a result of the combined loss of CII and CIV in 24.3% of cells. A large pro-
portion of patient SN neurons (35.4%) also showed isolated SDHA deficiency, (M) causing the frequency distribution of SDHA:-
COXI to shift toward lower SDHA levels. *p<0.05, **p<0.01. COXI5 cytochrome c oxidase subunit I; GRP755heat shock
70kDa protein 9 (mortalin); NDUFA135NADH dehydrogenase 1 alpha subcomplex 13; r25Spearman correlation coefficient;
SDHA5 succinate dehydrogenase complex subunit A. [Color figure can be viewed in the online issue, which is available at
www.annalsofneurology.org.]
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replication events in NDUFA13-negative IPD patient
neurons. By contrast, mtDNA major arc deletions did
not correlate with CI abundance in individually laser-
captured patient neurons (data not shown).
Discussion
Applying quadruple immunofluorescence to postmortem
SN sections, we performed a detailed single-neuron level
characterization of respiratory chain deficiency in IPD.
FIGURE 3: Correlation of respiratory chain complex abundances in substantia nigra neurons of controls with age. Plotting of
the average neuronal NDUFB8:porin (A) and COXI:porin (B) against age at death revealed age-associated declines. COX-
I5 cytochrome c oxidase subunit I; NDUFB85NADH dehydrogenase 1 beta subcomplex 8; n.s.5not significant; r25Spearman
correlation coefficient. [Color figure can be viewed in the online issue, which is available at www.annalsofneurology.org.]
FIGURE 4: Abundance of mtDNA-associated TFAM and TFB2M in patient and control (Cnt) substantia nigra neurons. (A) Epiflu-
orescence microscopy after triple-label immunofluorescence indicated joint loss of NDUFB8 and TFAM in idiopathic Parkinson
disease (IPD) patients, whereas porin staining showed normal mitochondrial mass. (B) Densitometric analysis of investigated
proteins confirmed significantly reduced TFAM:porin ratios in IPD patients. Lines represent mean group ratios. (C) In patients
and controls, NDUFB8 and TFAM strongly correlated at the single-neuron level, resulting in similar behaviors of the frequency
histograms for NDUFB8:TFAM. (D) Triple-label immunohistochemistry showed reduced abundances of NDUFB8 and TFB2M but
normal porin levels in IPD neurons. (E) Densitometric analysis of average neuronal TFB2M and porin levels in patients and con-
trols revealed a significant reduction of TFB2M:porin in the former. (F) The frequency distribution of the NDUFB8:TFB2M ratio
in single neurons showed a slight shift toward lower TFB2M in patient cells. *p<0.05. NDUFB85NADH dehydrogenase 1 beta
subcomplex 8; TFAM5mitochondrial transcription factor A; TFB2M5mitochondrial transcription factor B2.
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This high-resolution quantitative approach enabled us to
evaluate the relationship between the mitochondria-
normalized abundances of respiratory chain CI–IV. First,
we confirmed experimental results from the late 1980s
indicating CI (nicotinamide adenine dinucleotide ubiqui-
none oxidoreductase) deficiency in SN homogenates in
IPD.4 In our hands, this deficiency in individual IPD
SN neurons corresponded to a loss of CI (NDUFB8 and
NDUFA13) protein levels normalized for mitochondrial
mass. We furthered our analysis by quantifying the abun-
dance of a subunit of CII (SDHA), which represents the
only respiratory chain complex entirely composed of
nuclear-encoded proteins. To our surprise, IPD patient
SN neurons contained significantly lower levels of
SDHA, suggesting an involvement of both nuclear and
mitochondrial factors in IPD pathogenesis. By contrast,
the average protein levels of subunits of respiratory chain
CIII (UQCRC2) and CIV (COXI) were comparable in
nigral neurons of IPD patients and aged controls. CI and
CII deficiencies occurred in the absence of changes in
neuronal mitochondrial content, thus implicating specific
molecular mechanisms that result in qualitative mito-
chondrial respiratory chain deficiency.
In addition to the well-established CI deficit, also
CIV dysfunction has previously been implicated in the
pathogenesis of IPD.6,7 Benefiting from the high specific-
ity and resolution of our single-cell immunofluorescence
approach, we studied the quantitative relationships
between CI, CII, and CIV as an index of their coregula-
tion in SN neurons. In agreement with the common
dependency of CI and CIV assembly and function on
the mitochondrial genome,29 NDUFA13 and COXI
abundances were strongly correlated in single control and
patient neurons. The majority of dysfunctional patient
SN neurons demonstrated either isolated CI, or com-
bined CI and CIV deficiencies, with few cells exhibiting
selective loss of CIV. From this observation, we deduced
that CIV deficiency in nigral neurons only occurs in the
presence of CI deficiency in IPD. This molecular signa-
ture may arise from mtDNA alterations as discussed
below.
CI and CII as well as CIV and CII were loosely
linked in control neurons. However, in patient SN neu-
rons, the associations between NDUFA13 and SDHA as
well as between COXI and SDHA increased to the level
of coregulation of NDUFA13 and COXI. The joint
occurrence of CI, CII, and CIV deficiencies in IPD
patient neurons (despite none of the subunits of CII
being encoded by the mitochondrial genome) suggested
that nuclear signaling pathways, such as the nuclear respi-
ratory factor (NRF)1/2 pathway, are involved in the loss
of respiratory chain complexes. The NRF1/2 path-
way30,31 not only controls the transcription of all CII
subunits (and of some subunits of CI and CIV) but also
directly regulates the mRNA expression of the mtDNA
transcription factors TFAM24 and TFB2M.28
One reason why CII deficiency was not detected in
a previous study on postmortem midbrain sections from
the Newcastle PD cohort may be different methodology.6
Whereas our new image analysis method allows detection
of subtle changes in protein levels within each tested neu-
ron in a quantitative manner, previously applied visual
FIGURE 5: mtDNA analysis in pooled substantia nigra neurons isolated from control (Cnt) and idiopathic Parkinson disease
(IPD) patient midbrain sections. Simultaneous real-time polymerase chain reaction quantification of mtDNA fragments in ND1
and the D-loop in 30 neurons per person and experiment from 10 controls and 9 IPD patients are shown. This analysis indi-
cated significantly reduced (A) mtDNA copy numbers (ND1:area) and (B) D-loop:ND1 ratios in IPD patients compared to con-
trols. *p<0.05, **p<0.01. ND15NADH dehydrogenase 1. [Color figure can be viewed in the online issue, which is available at
www.annalsofneurology.org.]
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classification schemes distinguished only between enzy-
matically completely SDH-negative and -positive neu-
rons. The same holds true for COXI deficiency in single
neurons. Employing quantitative immunofluorescence,
we detected subtle CIV deficits in SN neurons of aged
controls that appear to even out the previously observed
small shift toward CIV deficiency in the PD patients.6
To test the potential role of nuclear signaling in
IPD further, we investigated the abundance of TFAM
and TFB2M in nigral neurons from patients and con-
trols. Both proteins correlated with CI levels at the
single-cell level and were reduced in patient tissue, impli-
cating downregulated transcription of mtDNA genes as a
potential factor in the development of CI deficiency in
IPD. However, both TFAM and TFB2M are also
required for transcription-primed replication of the mito-
chondrial genome,24,28 opening the possibility that
mtDNA depletion contributes to respiratory chain defi-
ciency in IPD.
To explore this hypothesis, we performed real-time
PCR analysis of the mitochondrial genome in pooled
patient and control SN neurons. Patient neurons
FIGURE 6: mtDNA real-time polymerase chain reaction analysis in individually isolated patient substantia nigra neurons with
high or low CI abundance. (A) Determination of the ND1:area ratio in single NDUFA13-positive and NDUFA13-negative neu-
rons from 5 idiopathic Parkinson disease (IPD) patients showed significantly reduced mtDNA copy numbers in the latter cells.
(B) On average, NDUFA13-negative patient neurons contained 29.4% fewer mtDNA copies than NDUFA13-positive patient
neurons. (C, D) Impaired mtDNA transcription/replication was indicated by a significant reduction in the D-loop:ND1 ratio in
NDUFA13-negative neurons of all patients. *p<0.05. ND15NADH dehydrogenase 1; NDUFA135NADH dehydrogenase 1
alpha subcomplex 13. [Color figure can be viewed in the online issue, which is available at www.annalsofneurology.org.]
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contained fewer mtDNA copies and less mtDNA replica-
tion/transcription-associated 7S DNA than control cells.
Further linking mtDNA depletion to loss of CI in IPD,
individually isolated CI-deficient patient neurons con-
tained even fewer mtDNA copies and 7S molecules than
their counterparts with normal CI levels. In keeping with
these findings, increased exposure of the mitochondrial
genome to TFAM has been reported to enhance 7S
DNA association and mtDNA replication in an in organ-
ello DNA synthesis system.32 In line with our hypothesis
stating that TFAM deficiency induces mtDNA depletion
in IPD, conditional silencing of TFAM provokes PD-like
features such as respiratory chain dysfunction, degenera-
tion of dopaminergic SN neurons, and progressive
impairment of motor function in mice.33,34 Remarkably,
in addition to its effect as a CI inhibitor, the PD-
inducing reagent 1 methyl-4-phenylpyridinium also
interferes with mtDNA replication by destabilization of
the mitochondrial D-loop.35,36 Hence, our molecular
results converge with these findings to indicate that
toxin-induced parkinsonism and the actual movement
disorder may share a common molecular origin, namely
disrupted mtDNA transcription and replication.
It is curious why CI and CII are seemingly more
affected by impaired nuclear transcription activation and
mtDNA depletion in IPD SN neurons than CIII and
CIV. This discrepancy, however, was previously observed
in a histopathology study on Alper syndrome, a primary
mtDNA replication defect. In these individuals with a
mutation in the mtDNA polymerase gamma (POLG)
gene, mtDNA depletion resulted in isolated CI (but not
CIV) deficiency.37 Preferential degradation of CI in Alper
syndrome and of CI and CII in IPD may be due to
lower total abundances of these complexes in respect to
CIII and CIV. The stoichiometric ratios of the respira-
tory chain complexes have been measured as CI, 0.8–1.3;
CII, 1.2–1.4; CIII, 3; and CIV, 6.0–7.5 in bovine heart
mitochondria.38 Thus, CIV may exist in excess, whereas
CI levels may be limiting. Moreover, the quantification
of respiratory chain protein turnover rates in mice
showed that the subunits of CII have the shortest average
half-life, followed by the components of CI and CIV,
whereas the components of CIII have the longest half-
life.39 The high stability of the CIII subunits potentially
explains why this complex behaves differently from CI
and CII, despite relatively similar stoichiometric propor-
tions. An alternative scenario underlying our immunohis-
tochemical and real-time PCR results may be that SN
neurons lacking functional CIII and CIV (and harboring
deletions) are more prone to degeneration and are thus
undetectable in postmortem tissue. This would lead to a
selection bias where CIII and CIV deficiencies would
escape our analysis, yielding the current histopathological
picture where CI and CII deficiencies predominate.
Whereas our study exclusively focused on respira-
tory chain deficiencies in dopaminergic neurons of the
SN, it would be interesting to explore whether the
described respiratory chain and mtDNA phenotypes
extend to other areas of the brain known to be affected
in the early and late phases of IPD. According to the
staging scheme by Braak and colleagues,40 neuronal
pathology in IPD evolves from the olfactory bulb and
the dorsal motor nucleus via the locus ceruleus and the
SN to the basal forebrain and amygdala, finally reaching
the medial temporal lobe structures and the cerebral cor-
tex.40,41 Single-cell analyses in these specific brain regions
would help to further elucidate the contribution of mito-
chondrial dysfunction to disease progression.
In summary, our findings link respiratory chain defi-
ciencies to both nDNA and mtDNA elements in nigral
neurons of IPD patients. Possibly as a consequence of
impaired NRF1/2 signaling, the transcription of nuclear-
encoded subunits of the respiratory chain complexes and of
the mitochondrial transcription factors TFAM and TFB2M
is compromised in IPD. Lack of TFAM packaging of the
mitochondrial genome causes D-loop destabilization and
hampers mtDNA transcription and replication. In turn, a
reduction in mtDNA copy number and transcripts potenti-
ates respiratory chain dysfunction, which is primarily
reflected in the loss of CI. By contrast, CIV deficiency
appears only together with CI deficiency, possibly represent-
ing a later phase of respiratory chain impairment that may
precipitate neuronal loss. Although mtDNA deletions have
previously been associated with CIV deficiency in IPD, our
results reveal that quantitative differences in mtDNA abun-
dance and replication more specifically discriminate between
CI-normal and CI-deficient SN neurons. Our detailed
single-cell analysis of respiratory chain proteins further
expands the mitochondrial phenotype of IPD to include
CII deficiency, which largely correlates with the loss of CI.
The heretofore-suspected predominant defect of CI is likely
only the most pronounced sign of a manifold picture of
respiratory chain complex deficiencies arising from impaired
mitochondrial–nuclear signaling in IPD.
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